Drug intelligence / Profile preview

Fortify

Development stage: Unknown
Lead developer: HEVA
Modality: Small Molecules
Administration: Oral

Overview

Fortify is a specialized blend designed to naturally boost testosterone levels and support men's physical and sexual health. It combines enclomiphene, a selective estrogen receptor modulator (SERM), with key nutrients, hormonal precursors, and herbal supplements. Enclomiphene works by blocking estrogen receptors, which can lead to an increase in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion, thereby stimulating endogenous testosterone production.

Brand names: Fortify

Targets

ER (Estrogen receptor)

Beyond the preview

Go deeper on Fortify.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fortify.

Explore the full profile